In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
15 Aug, 2024, 02.26 PM IST
First-ever phase-three clinical trial for dengue vaccine initiated in IndiaThe Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...
14 Aug, 2024, 11.30 PM IST
Panacea Biotec completes Phase I/II study of DengiAlI vaccineAccording to the World Health Organization, dengue represents one of the 10 biggest global health threats and it is critical to have access...
24 Sep, 2020, 04.16 PM IST